ETOPOSIDE AND TENIPOSIDE - BIOANALYSIS, METABOLISM AND CLINICAL PHARMACOKINETICS

被引:55
作者
HOLTHUIS, JJM [1 ]
机构
[1] STATE UNIV UTRECHT, FAC PHARM, DEPT PHARMACEUT ANAL, 3511 GH UTRECHT, NETHERLANDS
关键词
D O I
10.1007/BF01959294
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
引用
收藏
页码:101 / 116
页数:16
相关论文
共 100 条
[1]  
AHERNE GW, 1982, CANCER CHEMOTH PHARM, V7, P117
[3]  
ALLEN LM, 1976, P AM ASSOC CANC RES, V17, P6
[4]   ANALYSIS OF 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
ALLEN, LM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) :1440-1441
[5]   COMPARISON OF HUMAN PHARMACOKINETICS OF VM-26 AND VP-16, 2 ANTINEOPLASTIC EPIPODOPHYLLOTOXIN GLUCOPYRANOSIDE DERIVATIVES [J].
ALLEN, LM ;
CREAVEN, PJ .
EUROPEAN JOURNAL OF CANCER, 1975, 11 (10) :697-707
[6]  
BEIJNEN JH, 1988, J INT PHARM, V41, P169
[7]  
BENNETT CL, 1987, CANCER RES, V47, P1952
[8]  
BRINDLEY CJ, 1985, CANCER CHEMOTH PHARM, V15, P66
[9]   HORSERADISH-PEROXIDASE HYDROGEN PEROXIDE-CATALYZED OXIDATION OF VP16-213 - IDENTIFICATION OF A NEW METABOLITE [J].
BROGGINI, M ;
ROSSI, C ;
BENFENATI, E ;
DINCALCI, M ;
FANELLI, R ;
GARIBOLDI, P .
CHEMICO-BIOLOGICAL INTERACTIONS, 1985, 55 (1-2) :215-224
[10]  
CANAL P, 1985, CANCER CHEMOTH PHARM, V15, P149